Oncology
Home / Our therapy areas / Oncology
Transforming Cancer Care
We’re pushing the boundaries of science to deliver life-changing medicines customized to the needs of every patient. Our progress across our six scientific platforms – Immuno-Oncology, Tumour Drivers and Resistance, DNA Damage Response, Antibody Drug Conjugates, Epigenetics, and Cell Therapies - have helped improve the patient experience while developing therapies that hold the promise of new possibilities..
Redefining the Cancer Journey
Aspirations for early detection exist, but unfortunately, they are not always met in practice. For many people, cancer goes undetected until it is in advanced stages, or returns after initial treatment. We seek to create medicines and combinations aiming to set new standards for patient outcomes by redefining the patient journey, from the point of diagnosis to survival
Our Disease Areas
Our goal is to offer solutions to every form of cancer, being as diverse as the conditions themselves.
We are focusing on some of the most hard-to-treat cancers including pancreatic cancer, certain blood cancers, and cancers within breast, lung, ovary, and prostate.
Our People and Culture
We know we can only make the most significant scientific and cancer care advancements with the most talented team. Propelled by an ambitious vision, our people follow the science to discover, develop and deliver innovative solutions, with one goal in mind, to redefine cancer care.
Leading a Revolution Through Collaboration
Despite huge advances in cancer care, we know that fighting cancer needs a collective and collaborative approach.
From drug discovery collaborations to commercial partnerships, we are sourcing new medicines, investing in the brightest minds and funding research across the globe, enabling all the members of the care team to work together to achieve cancer remission.
Our Medicines
We are leaders in developing medicines and maximising their potential wherever possible.
We’re using diverse scientific approaches to tackle cancer, exploring combinations to optimize treatment responses. The goal is to improve the quality of life of cancer patients by enabling access to novel treatment solutions
Latest Updates
Approval ID: IN-15382 | Approved Date: 13/11/2024 | Expiration Date: 13/11/2026